SCIESCOPUSQ2
Antibody Therapeutics
OXFORD UNIV PRESS, United States
Antibody Therapeutics is an academic journal published by OXFORD UNIV PRESS (United States). Identifiers: eISSN 2516-4236. Indexed in SCIE, SCOPUS. Metrics: JIF 4.5, CiteScore 8.4, SJR 1.314, SNIP 1.16. tlooto lists 317 papers from this journal.
CiteScore
8.40
Scopus citation metric
SJR
1.314
SCImago rank
SNIP
1.16
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2516-4236
- Abbreviation
- ANTIBODY THER
- Publisher
- OXFORD UNIV PRESS
- Country
- United States
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
2403 Immunology2723 Immunology and Allergy
Papers in this journal
Recent papers
- Preventing Physical and Chemical Degradation of the LABL-fc-MOGR5, a Bifunctional Peptide Inhibitor, with Formulation Development Approaches
2026
- Integrating Fab Phage and Yeast Display through Seamless Transfer of Paired Heavy and Light Chain Libraries for Efficient Antibody Discovery
2026
- A hyperimmune ovine antibody-based therapeutic candidate against Crimean-Congo haemorrhagic fever virus targeted to the Gn and Gc glycoproteins: high antibody levels with neutralization activity but lack of protective efficacy in a mouse model.
2026
- Systematic functional screening of immunoreceptor tyrosine-based inhibitory motif domains identifies potent inhibitory modules for chimeric antigen receptor-T
2026
- Ultrahigh DAR Antibody–Drug Conjugates: Advancing the Next Generation of Targeted Therapy
2026
Most cited papers
- The global landscape of approved antibody therapies
2022 · 161 citations
- Trastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers
2018 · 136 citations
- US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives
2021 · 115 citations
- Macrophage checkpoint blockade: results from initial clinical trials, binding analyses, and CD47-SIRPα structure–function
2020 · 113 citations
- Enhancing antibody-dependent cell-mediated cytotoxicity: a strategy for improving antibody-based immunotherapy
2018 · 102 citations